Suppr超能文献

CD40 糖型和 TNF 受体 1 和 2 在自身免疫中 CD40 受体的形成。

CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

机构信息

Department of Medicine and Webb-Waring Center, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

Mol Immunol. 2010 Aug;47(14):2303-13. doi: 10.1016/j.molimm.2010.05.288. Epub 2010 Jun 19.

Abstract

The CD40-CD154 dyad is an intensely studied field as is glycosylation status and both impact immunological functions and autoimmune conditions. CD40 has several isoforms, is modified by glycosylation, and trimerizes to form the functional receptor. We described a CD4(+)CD40(+) T cell (Th40) subset which is expanded in autoimmunity and is necessary and sufficient in transferring type 1 diabetes. Glycosylation impacts immunological events and T cells from autoimmune mouse strains express 30-40% less GlcNAc-branched N-glycans than T cells from non-autoimmune strains, a decrease known to activate T cells. Here we demonstrate that several CD40 receptor constellations exist on CD4 T cells. However, rather than containing different isoforms of CD40 they contain different glycoforms of isoform I. The glycoform profile is dependent on availability of CD154 and autoimmune NOD mice express a high level of a less glycosylated form. Interestingly, CD40 stimulation induces some CD40 receptor constellations that contain TNF-receptors 1 and 2 and targeting of those alters CD40 signaling outcomes in NOD Th40 cells. CD40-stimulation in vivo of non-autoimmune BALB/c mice expands the Th40 population and alters the CD40 glycoform profile of those cells to appear more like that of autoimmune prone NOD mice. Further understanding the dynamics and composition of the different CD40 receptor constellations will provide important insights into treatment options in autoimmunity.

摘要

CD40-CD154 二聚体是一个研究热点,糖基化状态也是如此,它们都影响免疫功能和自身免疫状况。CD40 有几种异构体,受糖基化修饰,三聚化形成功能性受体。我们描述了一种 CD4(+)CD40(+)T 细胞(Th40)亚群,该亚群在自身免疫中扩增,并在传递 1 型糖尿病中是必要和充分的。糖基化影响免疫事件,自身免疫小鼠株的 T 细胞表达的 GlcNAc 分支 N-糖链比非自身免疫株的 T 细胞少 30-40%,这一减少已知会激活 T 细胞。在这里,我们证明了 CD4 T 细胞上存在几种 CD40 受体构象。然而,它们不是包含不同的 CD40 异构体,而是包含 I 型异构体的不同糖型。糖型谱取决于 CD154 的可用性,自身免疫性 NOD 小鼠表达高水平的较少糖基化形式。有趣的是,CD40 刺激诱导一些包含 TNF 受体 1 和 2 的 CD40 受体构象,靶向这些受体改变了 NOD Th40 细胞中 CD40 信号转导的结果。在非自身免疫性 BALB/c 小鼠体内进行 CD40 刺激会扩增 Th40 群体,并改变这些细胞的 CD40 糖型谱,使其更类似于自身免疫倾向的 NOD 小鼠。进一步了解不同 CD40 受体构象的动态和组成将为自身免疫治疗提供重要的见解。

相似文献

1
CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.
Mol Immunol. 2010 Aug;47(14):2303-13. doi: 10.1016/j.molimm.2010.05.288. Epub 2010 Jun 19.
5
An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
J Immunol. 2013 Jul 15;191(2):717-25. doi: 10.4049/jimmunol.1300625. Epub 2013 Jun 17.
7
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.
Diabetologia. 2014 Nov;57(11):2366-73. doi: 10.1007/s00125-014-3342-5. Epub 2014 Aug 8.
9
Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.
Eur J Immunol. 2004 May;34(5):1488-97. doi: 10.1002/eji.200324703.
10
T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes.
Eur J Immunol. 2012 Mar;42(3):672-80. doi: 10.1002/eji.201142071.

引用本文的文献

4
A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019 Jul 15;332:8-15. doi: 10.1016/j.jneuroim.2019.03.013. Epub 2019 Mar 21.
5
A Drosophila Tumor Suppressor Gene Prevents Tonic TNF Signaling through Receptor N-Glycosylation.
Dev Cell. 2018 Jun 4;45(5):595-605.e4. doi: 10.1016/j.devcel.2018.05.012.
6
Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.
Front Endocrinol (Lausanne). 2017 Aug 23;8:208. doi: 10.3389/fendo.2017.00208. eCollection 2017.
8
Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
PLoS One. 2017 Feb 13;12(2):e0172037. doi: 10.1371/journal.pone.0172037. eCollection 2017.
10
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.
Diabetologia. 2014 Nov;57(11):2366-73. doi: 10.1007/s00125-014-3342-5. Epub 2014 Aug 8.

本文引用的文献

2
The co-evolution of our understanding of CD40 and inflammation.
Diabetologia. 2009 Jun;52(6):997-9. doi: 10.1007/s00125-009-1357-0. Epub 2009 Apr 10.
3
The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes.
Diabetologia. 2009 Jun;52(6):1152-63. doi: 10.1007/s00125-009-1267-1. Epub 2009 Jan 31.
4
CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.
J Autoimmun. 2008 Dec;31(4):385-92. doi: 10.1016/j.jaut.2008.09.001. Epub 2008 Oct 31.
5
Mammalian glycosylation in immunity.
Nat Rev Immunol. 2008 Nov;8(11):874-87. doi: 10.1038/nri2417.
8
The role of platelet CD154 in the modulation in adaptive immunity.
Immunol Res. 2007;39(1-3):185-93. doi: 10.1007/s12026-007-0074-3.
9
N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration.
J Biol Chem. 2007 Nov 16;282(46):33725-33734. doi: 10.1074/jbc.M704839200. Epub 2007 Sep 13.
10
TRAF proteins in CD40 signaling.
Adv Exp Med Biol. 2007;597:131-51. doi: 10.1007/978-0-387-70630-6_11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验